Back to Search Start Over

ERTUGLIFLOZIN VERSUS DAPAGLIFLOZIN FOR PREVENTION OF HEART FAILURE EVENTS IN PATIENTS WITH REDUCED EJECTION FRACTION: NUMBER NEEDED TO TREAT AND ITS ASSOCIATED COSTS

Authors :
Ariel Hammerman
Joseph Azuri
Enis Aboalhasan
Ronen Arbel
Source :
Journal of the American College of Cardiology. 77:776
Publication Year :
2021
Publisher :
Elsevier BV, 2021.

Subjects

Subjects :
medicine.medical_specialty
Ejection fraction
business.industry
medicine.disease
chemistry.chemical_compound
chemistry
Internal medicine
Heart failure
medicine
Cardiology
Number needed to treat
Ertugliflozin
In patient
Dapagliflozin
Cardiology and Cardiovascular Medicine
business

Details

ISSN :
07351097
Volume :
77
Database :
OpenAIRE
Journal :
Journal of the American College of Cardiology
Accession number :
edsair.doi...........179abc1e43055e0cf99470edb5d1d51a

Tools

Authors Abstract Subjects Details